Abstract
In this study, we found that gene expression of the human β-galactoside α2,6-sialyltransferase (hST6Gal I) was specifically increased during differentiation of human MG-63 osteoblastic cells by serum starvation (SS). In parallel, a distinct increase in binding to SNA, the α2,6-sialyl-specific lectin, was observed in serum-starved cells, as demonstrated by FACS analysis. 5’-Rapid amplification of cDNA ends analysis demonstrated that the increase of hST6Gal I transcript by SS is mediated by P1 promoter. To elucidate transcriptional regulation of hST6Gal I in SS-induced MG-63 cells, we functionally characterized the P1 promoter region of the hST6Gal I gene. The 5’-deletion analysis of P1 promoter region revealed that the 189 bp upstream region of transcription start site is critical for transcriptional activity of hST6Gal I gene in SS-induced MG-63 cells. This region contains the predicted binding sites for several transcription factors, including AREB6, FOXP1, SIX3, HNF1, YY2, and MOK2. The mutagenesis analysis for these sites and chromatin immunoprecipitation assay demonstrated that the YY2 binding site at -98 to -77 was essential for the SS-induced hST6Gal I gene expression during differentiation of MG-63 cells.
Similar content being viewed by others
References
Dall’Olio, F.: The sialyl-α2,6-lactosaminyl-structure: biosynthesis and functional role. Glycoconj. J. 17, 669–676 (2000)
Dall’Olio, F., Chiricolo, M.: Sialyltransferases in cancer. Glycoconj. J. 18, 841–850 (2001)
Lu, J., Gu, J.: Significance of β-galactoside α2,6 sialyltranferase 1 in cancers. Molecules. 20, 7509–7527 (2015)
Dall’Olio, F., Malagolini, N., di Stefano, G., Minni, F., Marrano, D., Serafini-Cessi, F.: Increased CMP-NeuAc:Gal β1,4GlcNAc-R α2,6 sialyltransferase activity in human colorectal cancer tissues. Int. J. Cancer. 44, 434–439 (1989)
Gessner, P., Riedl, S., Quentmaier, A., Kemmner, W.: Enhanced activity of CMP-NeuAc:Galβ1-4GlcNAc:α2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients. Cancer Lett. 5, 143–149 (1993)
Recchi, M.A., Hebbar, M., Hornez, L., Harduin-Lepers, A., Peyrat, J.P., Delannoy, P.: Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res. 58, 4066–4070 (1998)
Recchi, M.A., Harduin-Lepers, A., Boilly-Marer, Y., Verbert, A., Delannoy, P.: Multiplex RT-PCR method for the analysis of the expression of human sialyltransferases: application to breast cancer cells. Glycoconj J. 15, 19–27 (1998)
Dall’Olio, F., Chiricolo, M., D’Errico, A., Gruppioni, E., Altimari, A., Fiorentino, M., Grigioni, W.F.: Expression of β-galactoside α2,6 sialyltransferase and of α2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis. Glycobiology. 14, 39–49 (2004)
Wang, P.H., Li, Y.F., Juang, C.M., Lee, Y.R., Chao, H.T., Tsai, Y.C., Yuan, C.C.: Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix. Gynecol. Oncol. 83, 121–127 (2001)
Kaneko, Y., Yamamoto, H., Kersey, D.S., Colley, K.J., Leestma, J.E., Moskal, J.R.: The expression of Galβ1,4GlcNAc α2,6 sialyltransferase and α2,6-linked sialoglycoconjugates in human brain tumors. Acta Neuropathol. 91, 284–292 (1996)
Fukushima, K., Hara-Kuge, S., Seko, A., Ikehara, Y., Yamashita, K.: Elevation of α2→6 sialyltransferase and α1→2 fucosyltransferase activities in human choriocarcinoma. Cancer Res. 58, 4301–4306 (1998)
Skacel, P.O., Edwards, A.J., Harrison, C.T., Watkins, W.M.: Enzymic control of the expression of the X determinant (CD15) in human myeloid cells during maturation: the regulatory role of 6- sialytransferase. Blood 78, 1452–1460 (1991)
Dall’Olio, F., Chiricolo, M., Lau, J.T.Y.: Differential expression of the hepatic transcript of β-galactoside α2,6 sialyltransferase in human colon cancer cell lines. Int. J. Cancer. 81, 243–247 (1999)
Aas-Eng, D.A., Asheim, H.C., Deggerdal, A., Smeland, E., Funderud, S.: Characterization of a promoter region supporting transcription of a novel human β-galactoside α-2,6-sialyltransferase transcript in HepG2 cells. Biochim. Biophys. Acta 14, 166–169 (1995)
Taniguchi, A., Hasegawa, Y., Higai, K., Matsumoto, K.: Transcriptional regulation of human β-galactoside α2,6-sialyltransferase (hST6Gal I) gene during differentiation of the HL-60 cell line. Glycobiology. 10, 623–628 (2000)
Wang, X., Vertino, A., Eddy, R.L., Byers, M.G., Jani-Sait, S.N., Shows, T.B., Lau, J.T.: Chromosome mapping and organization of the human β-galactoside α2,6-sialyltransferase gene. Differential and cell-type specific usage of upstream exon sequences in B-lymphoblastoid cells. J. Biol. Chem. 268, 4355–4361 (1993)
Lo, N.W., Lau, J.T.: Transcription of the β-galactoside α2,6 sialyltransferase gene in B lymphocytes is directed by a separate and distinct promoter. Glycobiology. 6, 271–279 (1996)
Xu, L., Kurusu, Y., Takizawa, K., Tanaka, J., Matsumoto, K., Taniguchi, A.: Transcriptional regulation of human β-galactoside α2,6-sialyltransferase (hST6Gal I) gene in colon adenocarcinoma cell line. Biochem. Biophys. Res. Commun. 307, 1070–1074 (2003)
Grundmann, U., Nerlich, C., Rein, T., Zettlmeissl, G.: Complete cDNA sequence encoding human β-galactoside α-2,6-sialyltransferase. Nucleic Acids Res. 18, 667–668 (1990)
Wang, P.H., Lee, W.L., Lee, Y.R., Juang, C.M., Chen, Y.J., Chao, H.T., Tsai, Y.C., Yuan, C.C.: Enhanced expression of α2,6 sialyltransferase ST6Gal I in cervical squamous cell carcinoma. Gynecol. Oncol. 89, 395–401 (2003)
Nakashima, K., de Crombrugghe, B.: Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet. 19, 458–466 (2003)
Kihara, T., Ichikawa, S., Yonezawa, T., Lee, J.W., Akihisa, T., Woo, J.T., Michi, Y., Amagasa, T., Yamaguchi, A.: Acerogenin A, a natural compound isolated from Acer nikoense Maxim, stimulates osteoblast differentiation through bone morphogenetic protein action. Biochem. Biophys. Res. Commun. 406, 211–217 (2011)
Yoon, H.K., Lee, J.W., Kim, K.S., Mun, S.W., Kim, D.H., Kim, H.J., Kim, C.H., Lee, Y.C.: Serum deprivation-induced human GM3 synthase (hST3Gal V) gene expression is mediated by Runx2 in human osteoblastic MG-63 cells. Int. J. Mol. Sci. 17, E35 (2015)
Svensson, E.C., Conley, P.B., Paulson, J.C.: Regulated expression of α2,6-sialyltransferase by the liver-enriched transcription factors HNF-1, DBP, and LAP. J. Biol. Chem. 267, 3466–3472 (1992)
Nguyen, N., Zhang, X., Olashaw, N., Seto, E.: Molecular cloning and functional characterization of the transcription factor YY2. J. Biol. Chem. 279, 25927–25934 (2004)
Gordon, S., Akopyan, G., Garban, H., Bonavida, B.: Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene. 25, 1125–1142 (2006)
Wang, C.C., Chen, J.J., Yang, P.C.: Multifunctional transcription factor YY1: a therapeutic target in human cancer? . Expert Opin. Ther. Targets. 10, 253–266 (2006)
Behera, A.K., Kumar, M., Shanmugam, M.K., Bhattacharya, A., Rao, V.J., Bhat, A., et al.: Functional interplay between YY1 and CARM1 promotes oral carcinogenesis. Oncotarget. 10, 3709–3724 (2019)
Meng, Q., Ren, C., Wang, L., Zhao, Y., Wang, S.: Knockdown of ST6Gal-I inhibits the growth and invasion of osteosarcoma MG-63 cells. Biomed. Pharmacother. 72, 172–178 (2015)
Kasim, V., Xie, Y.D., Wang, H.M., Huang, C., Yan, X.S., Nian, W.Q., Zheng, X.D., Miyagishi, M., Wu, S.R.: Transcription factor Yin Yang 2 is a novel regulator of the p53/p21 axis. Oncotarget. 8, 54694–54707 (2017)
Tahmasebi, S., Jafarnejad, S.M., Tam, I.S., Gonatopoulos-Pournatzis, T., Matta-Camacho, E., Tsukumo, Y., et al.: Control of embryonic stem cell selfrenewal and differentiation via coordinated alternative splicing and translation of YY2. Proc. Natl. Acad. Sci. USA 113, 12360–12367 (2016)
Acknowledgements
This work was supported by the Dong-A University research fund.
Author information
Authors and Affiliations
Contributions
Conceived and designed the experiments: Miri Lee, Cheorl-Ho Kim, Young-Choon. Performed the experiments: Miri Lee, So-Young An, Hyun-Kyoung Yoon. Analyzed the data: Miri Lee, So-Young An, Hyun-Kyoung Yoon, Kyoung-Sook Kim, Dong-Hyun Kim, Cheorl-Ho Kim, Young-Choon Lee. Contributed reagents/materials/analysis tools: Dong-Hyun Kim, Hyun-Jun Kim, Kichoon Lee, Cheorl-Ho Kim. Wrote the paper: Miri Lee, Cheorl-Ho Kim, Young-Choon Lee.
Corresponding authors
Ethics declarations
Conflict of interest
The authors did not declare any competing interests in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the author.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
An, SY., Lee, M., Yoon, HK. et al. Regulation of human β-galactoside α2,6-sialyltransferase (hST6Gal I) gene expression during differentiation of human osteoblastic MG-63 cells. Glycoconj J 37, 681–690 (2020). https://doi.org/10.1007/s10719-020-09959-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-020-09959-3